| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0732-8893(03)00079-8 |
| P698 | PubMed publication ID | 12944016 |
| P50 | author | Reinaldo Salomao | Q40966026 |
| Michael A. Pfaller | Q62070176 | ||
| Shawn A Messer | Q62611307 | ||
| P2093 | author name string | Arnaldo Lopes Colombo | |
| Richard J Hollis | |||
| Analy S Azevedo Melo | |||
| Marcelo Briones | |||
| Robert F Crespo Rosas | |||
| P2860 | cites work | New and emerging yeast pathogens | Q30452880 |
| Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality | Q35811186 | ||
| Candida rugosa in immunocompromised infection. Case reports, drug susceptibility, and review of the literature | Q39809491 | ||
| Evaluation of pulsed-field gel electrophoresis as a typing system for Candida rugosa: comparison of karyotype and restriction fragment length polymorphisms | Q40010901 | ||
| Intravenous catheter-associated fungemia due to Candida rugosa | Q40222037 | ||
| National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog | Q43841591 | ||
| Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. | Q44318190 | ||
| National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species | Q45025194 | ||
| High rate of non-albicans candidemia in Brazilian tertiary care hospitals. | Q45262464 | ||
| Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit | Q46390977 | ||
| Evolutionary distances and identification of Candida species in clinical isolates by randomly amplified polymorphic DNA (RAPD). | Q48764719 | ||
| Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals | Q58840044 | ||
| The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance | Q71181685 | ||
| The epidemiology of hematogenous candidiasis caused by different Candida species | Q73441200 | ||
| P433 | issue | 4 | |
| P921 | main subject | amphotericin B | Q412223 |
| Candida rugosa | Q10441616 | ||
| candidemia | Q54946225 | ||
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 253-257 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Diagnostic Microbiology and Infectious Disease | Q15763479 |
| P1476 | title | Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy | |
| P478 | volume | 46 |
| Q46599492 | An outbreak of Pichia anomala fungemia in a Brazilian pediatric intensive care unit. |
| Q33410218 | Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. |
| Q30559661 | Candida mesorugosa sp. nov., a novel yeast species similar to Candida rugosa, isolated from a tertiary hospital in Brazil. |
| Q31064491 | Candida pseudorugosa sp. nov., a novel yeast species from sputum |
| Q30445379 | Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. |
| Q37634517 | Candida rugosa: a distinctive emerging cause of candidaemia. A case report and review of the literature |
| Q42958387 | Candida rugosa: a possible emerging cause of candidaemia in trauma patients |
| Q36199785 | Emerging fungal diseases |
| Q30834974 | Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008. |
| Q29616758 | Epidemiology of invasive candidiasis: a persistent public health problem |
| Q35073427 | Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species |
| Q49679766 | Fungal Biofilms and Polymicrobial Diseases |
| Q90423904 | Genome Assemblies of Two Rare Opportunistic Yeast Pathogens: Diutina rugosa (syn. Candida rugosa) and Trichomonascus ciferrii (syn. Candida ciferrii) |
| Q40343987 | Identification of pathogenic rare yeast species in clinical samples: comparison between phenotypical and molecular methods |
| Q42950831 | In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan |
| Q41833155 | In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. |
| Q51737787 | In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay. |
| Q34254380 | Molecular identification and antifungal susceptibility testing of clinical isolates of the Candida rugosa species complex and proposal of the new species Candida neorugosa |
| Q37581912 | Name Changes for Fungi of Medical Importance, 2012 to 2015. |
| Q25257510 | Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida |
| Q39795440 | Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. |
| Q35912243 | Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. |
| Q30447051 | Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. |
| Q35715408 | Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients |
| Q39169408 | Selection of orlistat as a potential inhibitor for lipase from Candida species |
| Q80082307 | Species diversity of yeast in oral colonization of insulin-treated diabetes mellitus patients |
| Q36289060 | The changing face of fungal infections in health care settings |
| Q51186546 | The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia. |
| Q39092291 | The global problem of antifungal resistance: prevalence, mechanisms, and management |
| Q40856899 | The isolation of Candida rugosa and Candida mesorugosa from clinical samples in Ghana |
| Q44863417 | The role of voriconazole in the treatment of emerging mycoses |
| Q37170218 | Treatment of invasive candidiasis in the elderly: a review |
| Q37196298 | Update on the genus Trichosporon |
Search more.